U.S.-based Pfizer Inc. and Ireland-based Allergan PLC today announced plans to merge, a move that would create the world’s largest drug manufacturer by sales volume. Under the so-called “inversion” deal, reportedly worth more than $150 billion, the new company, Pfizer PLC, would be based in Ireland, thereby significantly lowering its corporate tax rate. The companies said they expect the deal to close next year, after antitrust regulators, including the Federal Trade Commission, have completed their review.

Related News Articles

Headline
New research released today by the Deloitte Center for Health Solutions and Healthcare Financial Management Association offers key strategies for achieving…
Headline
AHA and AMGA members may apply through Oct. 20 to participate in an intensive learning collaborative on managing population health and succeeding in the new…
Headline
Anthem today asked the Supreme Court to review a federal appeals court decision blocking the health insurer’s proposed acquisition of Cigna.…
Headline
As urged by the AHA, the U.S. Court of Appeals for the District of Columbia Circuit today affirmed a district court decision blocking Anthem’s…
Headline
The House Judiciary Committee today voted 16-10 to approve the Standard Merger and Acquisition Reviews Through Equal Rules Act (H.R. 659), AHA-supported…
Headline
The Substance Abuse and Mental Health Services Administration is accepting applications for $22.6 million in fiscal year 2017 grants for states to work…